🇺🇸 FDA
Patent

US 7196074

Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof

granted A61PA61P15/00A61P15/10

Quick answer

US patent 7196074 (Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
96
CPC classes
A61P, A61P15/00, A61P15/10, A61P15/16, A61P21/06